Related Experiment Video
Updated: Dec 27, 2025
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.7K
Biomarkers in retinoblastoma
Jie Sun1, Hui-Yu Xi1,2, Qing Shao1
1Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
International Journal of Ophthalmology
|February 25, 2020
Summary
New biomarkers for retinoblastoma (RB), a common childhood eye cancer, offer improved diagnosis and treatment strategies. This review explores recent advances in RB biomarker discovery and their clinical applications.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Retinoblastoma (RB) is the most frequent intraocular cancer in children.
- RB is caused by the inactivation of the *Rb* genes.
- Early diagnosis significantly improves patient prognosis.
Purpose of the Study:
- To review recent advancements in the discovery of novel retinoblastoma biomarkers.
- To discuss the clinical utility and challenges of these biomarkers.
- To explore biomarker contributions to understanding RB pathogenesis and treatment strategies.
Main Methods:
- Literature review of recent studies on RB biomarkers.
- Focus on epigenetics, proteomics, and radiogenomics.
- Analysis of biomarker diagnostic and prognostic potential.
Main Results:
- Numerous new RB biomarkers have been identified.
- These biomarkers show potential in diagnosis and prognosis.
- Emerging research areas like epigenetics, proteomics, and radiogenomics are yielding promising findings.
Conclusions:
- New biomarkers are crucial for improving retinoblastoma diagnosis and treatment.
- Further research is needed to overcome challenges in clinical utility.
- Biomarker discovery aids in understanding RB pathogenesis and personalizing treatment.
